Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 21, 2025Blood ResearchOpen Access

Real-world data on long-term outcomes in patients with T-cell lymphomas: a nationwide study of Korea

View Full Paper
Ask AI
Bookmark
Share

Authors

DBDong Won BaekKyungpook National University HospitalJLJungmin LeeUlsan CollegeYJYoung‐Eun JangEwha Womans University

Discussion

Loading...

Member takes

Implication

Retrospective analysis reveals improved survival rates in PTCL patients following autologous stem cell transplantation and CHOP regimen modifications.

Key Points

  • Patients receiving etoposide added to CHOP regimen showed improved progression-free survival and overall survival.
  • A total of 12,573 patients were included in the analysis, with common diagnoses being PTCL-NOS and extranodal NK/T-cell lymphoma.
  • Autologous stem cell transplantation significantly enhanced long-term survival rates, especially for PTCL-NOS and AITL subtypes.
  • The median follow-up period of 6.7 years revealed 3-year overall survival rates at 48.6% and 5-year rates at 43.5%.

Cite This Study

Baek et al. (2025) studied this question.

synapsesocial.com/papers/68af6d907567bf4f94feaf63https://doi.org/10.1007/s44313-025-00095-1
View Full Paper
Ask AI
Bookmark
Share